glp-1/gip agonist Targeting GLP-1, GIP & GCG in Obesity and Type 2 Diabetes Research Schematic illustration of monoagonists, dual

April 2026: The newly-consolidated NAION multidistrict litigation has 73 cases in its docket as of April 1, 2026

[DOI] [PMC free article] [PubMed] [Google Scholar] 77.Sinnathurai P., Lau W., Vieira de Ribeiro A.J., Bachovchin W.W., Englert H., Howe G., Spencer D., Manolios N., Gorrell M.D

Now, a randomized controlled trial published in the New England Journal of Medicine has found that exercise improves survival in patients with colorectal cancer

Iran War Wildfire Smoke World Politics Entertainment HealthWatch MoneyWatch Crime Space Sports Brand Studio The Free Press Local News Atlanta Baltimore Bay Area Boston Chicago Colorado Detroit Los Angeles Miami Minnesota New York Philadelphia Pittsburgh Sacramento Texas Live CBS News 24/7 Baltimore Bay Area Boston Chicago Colorado Detroit Los Angeles Miami Minnesota New York Philadelphia Pittsburgh Sacramento Texas 48 Hours 60 Minutes Shows 48 Hours 60 Minutes CBS Evening News CBS Mornings CBS Morning News CBS Reports CBS Saturday Morning The Daily Report The Dish Face the Nation Sunday Morning The Takeout Things That Matter The Uplift CBS News Investigates CBS News Confirmed Podcasts Newsletters Download Our App CBS News Team Executive Team Brand Studio Paramount+ Join Our Talent Community RSS Feeds U.S